Pharma sector likely to report weak numbers in Q4 Ruby Khatun Khatun9 April 2018 9:30 AM ISTThe troubled pharma sector is expected to report weak Q4 FY18 numbers, with PAT likely to decline by 9 percent (year-on-year) and appreciation in...
Medical studies in humans often launched on faulty evidence base: Report Medical Dialogues Bureau8 April 2018 8:07 PM ISTNew research reveals serious flaws in the animal studies that regulators and ethicists use to decide if an experimental drug should be tested in...
Parkway Pantai appoints Dr Ajay Bakshi as CEO of India operations Ruby Khatun Khatun8 April 2018 10:00 AM ISTNew Delhi: Parkway Pantai, one of Asia’s largest private healthcare service providers, has appointed Dr Ajay Bakshi as the Chief Executive Officer –...
Boehringer Ingelheim partners with OSE Immunotherapeutics to develop pioneering checkpoint inhibitor for advanced solid tumors Ruby Khatun Khatun8 April 2018 9:45 AM ISTBoehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, announced a...
Novo Nordisk buys blood drug licence to boost anaemic biopharma business Ruby Khatun Khatun8 April 2018 9:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk has secured the global license for U.S. biotech company EpiDestiny’s sickle cell disease (SCD) program in a...
Lupin gets EIR from USFDA for Pithampur facility Ruby Khatun Khatun7 April 2018 10:30 AM ISTNew Delhi: Drug firm Lupin said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Pithampur, Unit 1...
MTaI suggests gradual rollout of public procurement guidelines Ruby Khatun Khatun7 April 2018 10:00 AM ISTNew Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
AbbVie, Samsung Bioepis in deal, Humira biosimilar US release in 2023 Ruby Khatun Khatun7 April 2018 9:30 AM ISTAbbVie Inc said it signed a deal with Samsung Bioepis and its joint venture partner Biogen Inc that would fend off U.S. competition of their...
Johnson and Johnson loses trial over claims linking cancer to asbestos in talc Ruby Khatun Khatun7 April 2018 9:30 AM ISTJohnson and Johnson suffered its first trial loss in a lawsuit claiming its talc-based products including Johnson’s Baby Powder contain cancer-causing...
Delhi HC asks Fortis to respond to Daiichi's plea on hospital assets Ruby Khatun Khatun6 April 2018 11:10 AM ISTNew Delhi: The Delhi High Court asked Fortis Healthcare Ltd, which is going through the process of restructuring, to give its response on Japanese...
Glenmark to market Helsinn's chemo-induced nausea drug in India, Nepal Ruby Khatun Khatun6 April 2018 10:30 AM ISTMumbai: Glenmark Pharmaceuticals announced that it has entered into an exclusive licensing agreement with Swiss firm Helsinn Group to introduce...
UK MHRA completes inspection of Lupin's Goa plant Ruby Khatun Khatun6 April 2018 10:05 AM ISTNew Delhi: Pharma major Lupin said the UK health regulator has completed the inspection of its Goa facility without making any critical...
